REGENMED DEVELOPMENT ORGANIZATION

EIN: 202710571 501(c)(3) Medical Research

WINSTONSALEM, NC

Total Revenue
$1,168,019
Total Expenses
$1,183,238
Total Assets
$565,309
Net Assets
$-35,387
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2005
Legal Domicile
NC
Principal Officer
ANTHONY ATALA MD
Phone
3367164445
Tax Period
2023-01-01 to 2023-12-31

REGENMED DEVELOPMENT ORGANIZATION, founded in 2005, is a community nonprofit in the Medical Research sector that reported $1.2M in total revenue in fiscal year 2023. Revenue grew 18% year-over-year, indicating healthy expansion.

Mission

THE MISSION OF THE ORGANIZATION IS TO ACCELERATE THE DISCOVERY AND DEVELOPMENT OF APPLICATIONS OF NEW THERAPIES FOR DISEASE AND TRANSLATE THOSE THERAPIES INTO TREATMENTS FOR PATIENTS THROUGH THE SCIENCE OF REGENERATIVE MEDICINE. THE ORGANIZATION FOCUSES ON OBTAINING FEDERAL AND OTHER GRANT FUNDS AND WORKING WITH OTHER ORGANIZATIONS DEVELOPING REGENERATIVE MEDICINE AND PRODUCTS TO ACCOMPLISH ITS MISSION.

Program Service Accomplishments

Program 1
Expenses: $1,178,072 Revenue: $0

THE REGENMED DEVELOPMENT ORGANIZATION (REMDO) CONDUCTS RESEARCH TO DE-RISK TECHNOLOGIES AND SPEED UP THE TRANSLATION OF REGENERATIVE MEDICINE TECHNOLOGIES TO CLINICAL PRACTICE. REMDO WAS AWARDED...

Read more

THE REGENMED DEVELOPMENT ORGANIZATION (REMDO) CONDUCTS RESEARCH TO DE-RISK TECHNOLOGIES AND SPEED UP THE TRANSLATION OF REGENERATIVE MEDICINE TECHNOLOGIES TO CLINICAL PRACTICE. REMDO WAS AWARDED FUNDING FOR PROJECTS AIMED AT ACCELERATING MANUFACTURING INNOVATION FOR REGENERATIVE MEDICINE PRODUCTS. REMDO HAS ASSEMBLED A CONSORTIUM COMPRISED OF WORLD CLASS LEADERS IN REGENERATIVE MEDICINE RESEARCH AND DEVELOPMENT, BOTH COMMERCIAL AND ACADEMIC, TO EXECUTE ON ADVANCED BIOMANUFACTURING INITIATIVES. THE FUNDING WAS RECEIVED FROM THE MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM, A DEPARTMENT OF DEFENSE-FUNDED NONPROFIT ENTITY FORMED TO CONDUCT RESEARCH AND PROTOTYPING TO SUPPORT THE US ARMY MEDICAL RESEARCH AND MATERIEL COMMAND.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,168,019
Program Service Revenue $0
Investment Income $0
Other Revenue $0
TOTAL REVENUE $1,168,019

Expense Breakdown

Grants Paid $978,264
Salaries & Benefits $111,664
Fundraising Expenses $0
Program Expenses $1,178,072
Other Expenses $93,310
TOTAL EXPENSES $1,183,238

Year-over-Year Comparison

2023 2022 Change
Revenue $1,168,019 $985,996 +0.2%
Expenses $1,183,238 $1,017,608 +0.2%
Net Income $-15,219 $-31,612 -0.5%
Key Indicators
✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
5
Independent Members
1
Employees
N/A
Volunteers
5

Governance Policies

✓ Conflict of Interest Policy
✓ Whistleblower Policy
✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
4
$3,515,678
Total Directors
5
$3,515,678
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
ANTHONY ATALA MD CHAIR 0.50
Officer Director
$0 $54,475 $1,519,514
TERRY L HALES JR VICE CHAIR & TREASURER 0.10
Officer Director
$0 $56,067 $923,316
J REID MORGAN DIRECTOR & SECRETARY (TO 6/30/23) 0.50
Officer Director
$0 $108,874 $799,445
JULIE WATSON DIRECTOR & SECRETARY 0.50
Officer Director
$0 $19,081 $273,403
TERRY G WILLIAMS DIRECTOR 0.10
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $1,168,019 $1,183,238 $565,309 $-15,219
2022 $985,996 $1,017,608 $3,206,554 $-31,612
2021 $1,082,279 $1,094,909 $1,918,667 $-12,630
2021 $2,022,171 $2,066,818 $847,049 $-44,647
2020 $2,131,489 $2,169,249 $1,482,185 $-37,760
2019 $2,060,323 $2,107,241 $3,311,743 $-46,918
2018 $1,755,821 $1,800,880 $1,838,446 $-45,059
Explore More Nonprofits
→Top 100 Nonprofits in North Carolina →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare REGENMED DEVELOPMENT ORGANIZATION with other nonprofits in North Carolina and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.